Stability of SARS-CoV-2 phylogenies
The SARS-CoV-2 pandemic has led to unprecedented, nearly real-time genetic tracing due
to the rapid community sequencing response. Researchers immediately leveraged these …
to the rapid community sequencing response. Researchers immediately leveraged these …
Coronavirus, the king who wanted more than a crown: from common to the highly pathogenic SARS-CoV-2, is the key in the accessory genes?
N Chazal - Frontiers in Microbiology, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that emerged in late 2019,
is the etiologic agent of the current “coronavirus disease 2019”(COVID-19) pandemic, which …
is the etiologic agent of the current “coronavirus disease 2019”(COVID-19) pandemic, which …
Implications of SARS-CoV-2 mutations for genomic RNA structure and host microRNA targeting
A Hosseini Rad SM, AD McLellan - International journal of molecular …, 2020 - mdpi.com
The SARS-CoV-2 virus is a recently-emerged zoonotic pathogen already well adapted to
transmission and replication in humans. Although the mutation rate is limited, recently …
transmission and replication in humans. Although the mutation rate is limited, recently …
Potential therapeutic approaches of microRNAs for COVID-19: challenges and opportunities
A Farshbaf, N Mohtasham, R Zare… - Journal of oral biology …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) emerges as current outbreak cause by
Novel Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). This infection …
Novel Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). This infection …
Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study
Given the COVID-19 pandemic, currently, there are many drugs in clinical trials against this
virus. Among the excellent drug targets of SARS-CoV-2 are its proteases (Nsp3 and Nsp5) …
virus. Among the excellent drug targets of SARS-CoV-2 are its proteases (Nsp3 and Nsp5) …
Coronavirus genomes carry the signatures of their habitats
Coronaviruses such as SARS-CoV-2 regularly infect host tissues that express antiviral
proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host …
proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host …
Componential usage patterns in dengue 4 viruses reveal their better evolutionary adaptation to humans
G Li, L Shi, L Zhang, B Xu - Frontiers in Microbiology, 2022 - frontiersin.org
There have been at least four types of dengue outbreaks in the past few years. The
evolutionary characteristics of dengue viruses have aroused great concerns. The …
evolutionary characteristics of dengue viruses have aroused great concerns. The …
[PDF][PDF] Sars-Cov-2–the latest global threat and the prospect of COVID-19 therapy with the use of chitosan
K Pieklarz, Z Modrzejewska - … and Application of Chitin and its …, 2021 - bibliotekanauki.pl
Epidemics of infectious diseases have always been a threat to humanity and have
contributed to increased mortality in the affected areas. This also applies to a new species of …
contributed to increased mortality in the affected areas. This also applies to a new species of …
The long-term evolutionary history of gradual reduction of CpG dinucleotides in the SARS-CoV-2 lineage
S Subramanian - Biology, 2021 - mdpi.com
Simple Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
the coronavirus disease 2019 (COVID-19), a pandemic that infected over 81 million people …
the coronavirus disease 2019 (COVID-19), a pandemic that infected over 81 million people …
[HTML][HTML] Comparison of microbial diversity of respiratory tract between COVID-19 patients and healthy population
K Babišová, P Krumpolec, D Hadžega… - Acta …, 2023 - frontierspartnerships.org
Since its outbreak in late 2019, the SARS-CoV-2 virus has been the main subject of interest
for a number of studies. Clinical manifestations are ranging from asymptomatic to mild and …
for a number of studies. Clinical manifestations are ranging from asymptomatic to mild and …